Enter your email address
to be notified when new
courses become available.
|
These activities are jointly
sponsored by the University
of Wisconsin School of
Medicine and Public
Health (UWSMPH)
and CME Enterprise.
These activities are supported
by an educational grant
from Wyeth.
For easy access to comprehensive resources for antimicrobial resistance visit www.AREAinitiatives.org.
Your Gateway to a World of Knowledge!
|
|
INTRODUCTION
The advent of the antibiotic era profoundly reduced the suffering and mortality that civilization has endured throughout history because of bacterial infections. Yet today, clinicians find themselves on the front lines of the battle against antibiotic resistance, which has steadily increased over the past several decades. We soon may enter the nightmare of a post–antibiotic era—a time when many common infectious diseases no longer respond to antibiotic therapy. Only by waking up to this challenge can we avert a public health disaster of immeasurable proportions.
The aim of this CME series is to educate physicians on (1) clinical and microbiological data when determining pharmacological treatment, (2) individualized treatment plans based on severity of the infection, (3) dosing and duration of antimicrobial treatment specific to the organism and clinical setting, and (4) best practices in infection control to prevent transmission.
Each activity provides a maximum of 1 AMA PRA Category 1 Credit™. Please note that these courses are accredited only for physicians (MD, DO, or equivalent). All other participants will be issued a Letter of Completion for this activity, which may be accepted by a participants' licensing board as documentation of continuing education.
AVAILABLE COURSES
|
